NOVABIO Research Profile

What Is Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157)?

GLOW Blend is a named blend containing the GHK-Cu, TB-500, and BPC-157 components stated in the catalogue. This page identifies the material as GLOW Blend (GHK-Cu + TB-500 + BPC-157), with synonyms GHK-Cu + BPC-157 + TB-500 blend; physical form Lyophilized powder. The GLOW Blend identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations. This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Exact-product regulatory reviewLast verified 2026-10-06
Catalogue identityGLOW Blend (GHK-Cu + TB-500 + BPC-157)
Available specifications70mg
Evidence snapshot0 trials · 15 publications
Last verified2026-10-06

What Is Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157)?

GLOW Blend is a named blend containing the GHK-Cu, TB-500, and BPC-157 components stated in the catalogue. This page identifies the material as GLOW Blend (GHK-Cu + TB-500 + BPC-157), with synonyms GHK-Cu + BPC-157 + TB-500 blend; physical form Lyophilized powder. The GLOW Blend identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Evidence at a Glance

0ClinicalTrials.gov query records
15PubMed query records
6Selected publications shown

Sources: ClinicalTrials.gov query · PubMed query · Retrieved 2026-10-06

Mechanism & Pharmacology

The research record for GLOW Blend is organized around component-level product identification, multi-peptide comparison, analytical blend characterization, and catalogue-based research planning. For GLOW Blend, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Mechanistic or pathway language defines a research scope. It does not establish that a catalogue product produces a clinical effect.

Clinical Development

Selected exact-query registry records are shown below. Desktop displays up to six; mobile displays up to three.

NCT ID / StudyPhaseStatusContextLast registry update
No exact-match registry records were returned by the displayed query at the retrieval time.

Source: ClinicalTrials.gov search · Retrieved 2026-10-06

Selected Literature6 important records shown

Selected Literature

Selected PubMed record

Identification of a gamma-irradiated ingredient (garlic powder) in Korean barbeque sauce by thermoluminescence analysis.

Journal of food science · 2012 Apr

PMID 22394265
Selected PubMed record

Phase-Dependent Thermoluminescence Properties of Zinc Sulphide.

Journal of fluorescence · 2025 Aug

PMID 39625581
Selected PubMed record

Computational, optical and feasibility studies of organic luminescence TMB-PPT blend for photovoltaic application.

Heliyon · 2024 Feb 29

PMID 38370184
Selected PubMed record

Effects of Retinol, Natural Pea Peptide and Antioxidant Blend in a Topical Formulation: In Vitro and Clinical Evidence.

Dermatology and therapy · 2025 Jan

PMID 39720967
Selected PubMed record

The ugliness-in-averageness effect: Tempering the warm glow of familiarity.

Journal of personality and social psychology · 2017 Jun

PMID 28368135
Selected PubMed record

Diamond particles in toothpastes: in-vitro effect on the abrasive enamel wear.

BMC oral health · 2022 Jun 22

PMID 35733139

Source: PubMed search results · Retrieved 2026-10-06

Identity & ChemistryProduct-form fields

Identity & Chemistry

Compound / Blend
GLOW Blend (GHK-Cu + TB-500 + BPC-157)
Available Specifications
70mg
Pack Format
10 Vials
Synonyms
GHK-Cu + BPC-157 + TB-500 blend
Physical Form
Lyophilized powder

This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Source: NOVABIO product identity record · No single PubChem record is asserted for this catalogue entry.

Research Tools for Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157)

Review the selected registry records and open the module-level ClinicalTrials.gov query for the current result set.

Open Clinical Development

Use the complete NOVABIO documentation library to review currently available batch records.

Open Lab Results & COA
Storage & Laboratory HandlingDocumentation-led controls

Storage & Laboratory Handling

Confirm the exact material form, lot, supplied state and storage statement from the product label and corresponding batch documentation. Do not infer handling conditions from a different compound, strength or external clinical publication.

Regulatory Status

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Source: FDA Drugs@FDA · Checked 2026-10-06

Authoritative Data Summary

Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157) Research Summary

Identity

GLOW Blend (GHK-Cu + TB-500 + BPC-157); specifications: 70mg. This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product.

Mechanism

The research record for GLOW Blend is organized around component-level product identification, multi-peptide comparison, analytical blend characterization, and catalogue-based research planning. For GLOW Blend, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome.

Evidence

0 registry records and 15 PubMed records were returned by the displayed query on 2026-10-06; counts are not quality ratings.

Regulatory context

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157) is represented here by the catalogue identity GLOW Blend (GHK-Cu + TB-500 + BPC-157). This is a multi-component catalogue blend, so a single molecular formula, molecular weight or CAS number is not assigned to the combined product. The product record lists 70mg as the currently available specifications. The research context is organized around this product-specific scope: The research record for GLOW Blend is organized around component-level product identification, multi-peptide comparison, analytical blend characterization, and catalogue-based research planning. For GLOW Blend, those subjects define the literature and analytical context of this specific research peptide; they do not establish a clinical indication, administration route, or expected outcome. The synchronized searches returned 0 ClinicalTrials.gov records and 15 PubMed records for the displayed query. A registry count includes records with different designs, statuses and populations, while a publication count can include reviews, preclinical work and unrelated uses of a shared abbreviation; neither count is a quality score. For regulatory interpretation, FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval. Clinical findings apply only to the studied drug product, formulation, population and protocol. NOVABIO product specifications and batch documentation are separate catalogue records and do not inherit clinical outcomes from external studies. This profile supports identity checking, source tracing and laboratory record review; it does not certify a batch, recommend treatment, provide dosing instructions or replace current official labeling and professional judgment.

Sources: PubMed · ClinicalTrials.gov · FDA · NOVABIO product record

FAQ4 evidence-bounded answers

Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157) FAQ

What is Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157)?

GLOW Blend is a named blend containing the GHK-Cu, TB-500, and BPC-157 components stated in the catalogue. This page identifies the material as GLOW Blend (GHK-Cu + TB-500 + BPC-157), with synonyms GHK-Cu + BPC-157 + TB-500 blend; physical form Lyophilized powder. The GLOW Blend identifiers distinguish this catalogue entry from similarly named compounds, fragments, modified analogues, and multi-component formulations.

What research records are indexed for Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157)?

The synchronized query returned 0 ClinicalTrials.gov records and 15 PubMed records on 2026-10-06; review the linked searches because counts and record status can change.

Is Glycyl-L-histidyl-L-lysine Copper (GHK-Cu + TB-500 + BPC-157) FDA approved?

FDA status must be checked by exact drug product, formulation and indication; catalogue availability does not establish approval.

Does this page provide dosing guidance?

No. This research profile provides identity, evidence, chemistry, regulatory and documentation context without dosing or treatment instructions.

Sources, Methodology & Last Verified

Official sources
ClinicalTrials.gov, NCBI PubMed, FDA, available PubChem records, and NOVABIO product and COA records.
Query retrieved
2026-10-06T12:08:49Z
Inclusion
Exact identity terms and traceable registry, publication, chemistry, regulatory or catalogue fields.
Limitations
Search counts can include mixed evidence types and shared-name records; individual records require direct review.
Prepared by
NOVABIO Research
Reviewed date
2026-10-06
Editorial methodology
How NOVABIO builds Research Profiles
Corrections contact
Contact NOVABIO with the page URL and source record.